Go to the list of all blogs
John Y White's Avatar
published in Blogs
Oct 13, 2026
TickeronGET DAILY SIGNALS
FLYE vs MNDR: Comparing Two Small-Cap Stocks Navigating Tough Markets

FLYE vs MNDR: Comparing Two Small-Cap Stocks Navigating Tough Markets

Key Takeaways

  • FLYE is a U.S.-based electric vehicle company selling and renting e-bikes and e-scooters, while MNDR is a Singapore-based telehealth provider operating the MaNaDr platform.
  • Both are small-cap, early-stage companies that have experienced heavy share-price declines and undertaken capital-structure changes such as reverse stock splits (share consolidations).
  • FLYE has reported contracting revenue, widening net losses, and a "going concern" note from its auditors, signaling elevated financial risk.
  • MNDR has pointed to improving gross margin and a stronger cash position alongside reduced operating expenses in recent reporting periods.
  • The two companies operate in unrelated industries, making this a contrast between consumer discretionary/electric mobility exposure and healthcare technology exposure.

Setting the Scene: FLYE and MNDR

Comparing FLYE and MNDR offers a useful look at how two very different small-cap businesses are navigating difficult market conditions. Fly-E Group is an electric vehicle company, while Mobile-health Network Solutions is a telehealth operator. Although their industries share little in common, both stocks have faced similar pressures — falling share prices, shrinking valuations, and restructuring efforts. This stock comparison is most relevant for traders and investors who track relative performance and market positioning across speculative, early-stage companies, and who want a clearer view of where momentum, risk, and sentiment currently sit between the two names. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in their respective industries.

FLYE: Electric Mobility in Transition

FLYE, or Fly-E Group, Inc., designs, sells, and rents smart electric motorcycles, e-bikes, e-scooters, and related accessories under the "Fly E-Bike" brand. The company is headquartered in Flushing, New York, and serves food-delivery workers, urban commuters, and retail customers. In recent quarters, the business has been in a clear transition. Revenue has declined meaningfully year over year as the company closed or disposed of several retail stores and shifted its sales mix toward wholesale and a newer, higher-margin rental services line. Net losses have widened, and the company has reported limited cash on its balance sheet.

Recent market activity has reflected these challenges. The stock has traded far below its 52-week high, and its market capitalization has contracted to a few million dollars. The company has also implemented multiple reverse stock splits to maintain its exchange listing, changed auditors, and resolved a Nasdaq filing-compliance notice. Management has emphasized cost optimization and a pivot toward rental and wholesale channels as the core of its turnaround strategy. From what I see, these moves highlight the pressures on early-stage EV-related names.

MNDR: Telehealth Platform Dynamics

MNDR, or Mobile-health Network Solutions, is a Singapore-based telehealth company that operates the MaNaDr platform. The ecosystem connects patients with doctors through teleconsultations, prescription services, and medicine delivery, and also spans corporate wellness offerings through MaNaCare and pharmaceutical distribution through MaNaPharma. The company generates revenue across two main segments: telemedicine and other services, and the sale of medicine and medical devices.

In recent reporting periods, management has highlighted improving gross margin, a stronger cash position, and lower operating expenses — signals of a push toward greater cost discipline. The stock has nevertheless been highly volatile and has previously undergone a share consolidation (reverse stock split). As a small-cap name in the telehealth space, its relative performance has been sensitive to broader sentiment around growth-stage healthcare technology companies and to changes in its own liquidity and profitability trajectory. One thing that stands out here is how MNDR’s focus on efficiency contrasts with broader sector volatility.

Side-by-Side Analysis

The clearest contrast between FLYE and MNDR is their business model and sector exposure. FLYE sits in the consumer discretionary and electric-vehicle space, where demand is tied to discretionary spending and urban mobility trends. MNDR operates in digital healthcare, where growth drivers include telemedicine adoption, an aging population, and corporate wellness demand.

On momentum and financial health, the two names diverge. FLYE has faced contracting revenue, deeper losses, low cash reserves, and a "going concern" note from auditors — a flag indicating doubt about the company's ability to continue as a going concern over the next year. Its risk profile is elevated by internal-control weaknesses and repeated reverse stock splits. MNDR, by contrast, has emphasized improving margins, a stronger cash position, and reduced operating expenses, though it remains a small, volatile company that has also used a share consolidation. In terms of market positioning, FLYE is attempting a turnaround by exiting retail and leaning into higher-margin rental and wholesale revenue, while MNDR is focused on efficiency and margin expansion within an established platform business. I’m watching this closely as the operational signals differ markedly.

AI Insights on the Pair

Based on observable factors such as trend consistency, financial stability, and the presence of near-term catalysts, Tickeron's AI would likely view MNDR as the more favorably positioned of the two in the current environment. The company's emphasis on improving gross margin, strengthening cash, and reducing costs offers a more stable operational signal than the ongoing revenue declines and going-concern warnings surrounding FLYE. That said, both names carry meaningful risk, and any AI-generated view is inherently probabilistic rather than definitive. Relative positioning could shift quickly with new earnings, liquidity events, or sector-level catalysts, so the comparison is best treated as a snapshot of current conditions rather than a forecast.

Exploring AI Tools for Market Analysis

One resource I turn to for this type of side-by-side review is Tickeron’s Trending AI Robots. It shows how different automated strategies are positioned in the current environment across thousands of tickers, helping me gauge which approaches align best with prevailing conditions without relying on any single method.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MNDR, FLYE

Contributor

John Y White's AvatarJohn Y White|Beginner

Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active&section=trades&via=john


MNDR sees its Stochastic Oscillator ascends from oversold territory

On October 29, 2026, the Stochastic Oscillator for MNDR moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 33 instances where the indicator left the oversold zone. In 28 of the 33 cases the stock moved higher in the following days. This puts the odds of a move higher at over 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MNDR just turned positive on November 02, 2026. Looking at past instances where MNDR's MACD turned positive, the stock continued to rise in 6 of 15 cases over the following month. The odds of a continued upward trend are 40%.

Following a +8.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNDR advanced for three days, in 67 of 89 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNDR as a result. In 38 of 38 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNDR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.136) is normal, around the industry mean (4.523). P/E Ratio (-0.394) is within average values for comparable stocks, (12.601). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.536). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.112) is also within normal values, averaging (6.105).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. MNDR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNDR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 3.31B. The market cap for tickers in the group ranges from 708 to 49.18B. VEEV holds the highest valuation in this group at 49.18B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -13%. For the same Industry, the average monthly price growth was -13%, and the average quarterly price growth was 2%. DRIO experienced the highest price growth at 5%, while LFMD experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was 34% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 53
Price Growth Rating: 58
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: -5 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Industry
N/A
Address
2 Venture Drive
Phone
+65 62225223
Employees
89
Web
https://www.manadr.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.